CELYAD ONCOLOGY Stock Is 20% Down In The Last 10 Sessions
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid by a staggering 20.07% in 10 sessions from €1.08 to €0.86 at 19:10 EST on Wednesday, after two successive sessions in a row of gains. BEL 20 is dropping 0.52% to €3,666.07, after two successive sessions in a row of gains. About CELYAD ONCOLOGY Celyad…